[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Mumps Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

July 2024 | 89 pages | ID: GFCBB16BF83EEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Mumps Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Mumps Drug industry chain, the market status of Hospital (RIT 4385, Schwarz), Clinic (RIT 4385, Schwarz), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Mumps Drug.

Regionally, the report analyzes the Mumps Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Mumps Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Mumps Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Mumps Drug industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., RIT 4385, Schwarz).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Mumps Drug market.

Regional Analysis: The report involves examining the Mumps Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Mumps Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Mumps Drug:

Company Analysis: Report covers individual Mumps Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Mumps Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Mumps Drug. It assesses the current state, advancements, and potential future developments in Mumps Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Mumps Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Mumps Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • RIT 4385
  • Schwarz
  • Wistar RA 27/3
  • Others
Market segment by Application
  • Hospital
  • Clinic
  • Others
Major players covered
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Tiantan Biological Products Co., Ltd.
  • China National Pharmaceutical Group Corporation
  • GlaxoSmithKline Plc
  • Organic Vaccines
  • Prometheon Pharma, LLC
  • Sinovac Biotech Ltd.
  • Zydus Cadila Healthcare Limited
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Mumps Drug product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Mumps Drug, with price, sales, revenue and global market share of Mumps Drug from 2019 to 2024.

Chapter 3, the Mumps Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Mumps Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Mumps Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Mumps Drug.

Chapter 14 and 15, to describe Mumps Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Mumps Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Mumps Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 RIT 4385
  1.3.3 Schwarz
  1.3.4 Wistar RA 27/3
  1.3.5 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Mumps Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospital
  1.4.3 Clinic
  1.4.4 Others
1.5 Global Mumps Drug Market Size & Forecast
  1.5.1 Global Mumps Drug Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Mumps Drug Sales Quantity (2019-2030)
  1.5.3 Global Mumps Drug Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Beijing Minhai Biotechnology Co., Ltd
  2.1.1 Beijing Minhai Biotechnology Co., Ltd Details
  2.1.2 Beijing Minhai Biotechnology Co., Ltd Major Business
  2.1.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product and Services
  2.1.4 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
2.2 Beijing Tiantan Biological Products Co., Ltd.
  2.2.1 Beijing Tiantan Biological Products Co., Ltd. Details
  2.2.2 Beijing Tiantan Biological Products Co., Ltd. Major Business
  2.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product and Services
  2.2.4 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments/Updates
2.3 China National Pharmaceutical Group Corporation
  2.3.1 China National Pharmaceutical Group Corporation Details
  2.3.2 China National Pharmaceutical Group Corporation Major Business
  2.3.3 China National Pharmaceutical Group Corporation Mumps Drug Product and Services
  2.3.4 China National Pharmaceutical Group Corporation Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 China National Pharmaceutical Group Corporation Recent Developments/Updates
2.4 GlaxoSmithKline Plc
  2.4.1 GlaxoSmithKline Plc Details
  2.4.2 GlaxoSmithKline Plc Major Business
  2.4.3 GlaxoSmithKline Plc Mumps Drug Product and Services
  2.4.4 GlaxoSmithKline Plc Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 GlaxoSmithKline Plc Recent Developments/Updates
2.5 Organic Vaccines
  2.5.1 Organic Vaccines Details
  2.5.2 Organic Vaccines Major Business
  2.5.3 Organic Vaccines Mumps Drug Product and Services
  2.5.4 Organic Vaccines Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Organic Vaccines Recent Developments/Updates
2.6 Prometheon Pharma, LLC
  2.6.1 Prometheon Pharma, LLC Details
  2.6.2 Prometheon Pharma, LLC Major Business
  2.6.3 Prometheon Pharma, LLC Mumps Drug Product and Services
  2.6.4 Prometheon Pharma, LLC Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Prometheon Pharma, LLC Recent Developments/Updates
2.7 Sinovac Biotech Ltd.
  2.7.1 Sinovac Biotech Ltd. Details
  2.7.2 Sinovac Biotech Ltd. Major Business
  2.7.3 Sinovac Biotech Ltd. Mumps Drug Product and Services
  2.7.4 Sinovac Biotech Ltd. Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Sinovac Biotech Ltd. Recent Developments/Updates
2.8 Zydus Cadila Healthcare Limited
  2.8.1 Zydus Cadila Healthcare Limited Details
  2.8.2 Zydus Cadila Healthcare Limited Major Business
  2.8.3 Zydus Cadila Healthcare Limited Mumps Drug Product and Services
  2.8.4 Zydus Cadila Healthcare Limited Mumps Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Zydus Cadila Healthcare Limited Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: MUMPS DRUG BY MANUFACTURER

3.1 Global Mumps Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Mumps Drug Revenue by Manufacturer (2019-2024)
3.3 Global Mumps Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Mumps Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Mumps Drug Manufacturer Market Share in 2023
  3.4.2 Top 6 Mumps Drug Manufacturer Market Share in 2023
3.5 Mumps Drug Market: Overall Company Footprint Analysis
  3.5.1 Mumps Drug Market: Region Footprint
  3.5.2 Mumps Drug Market: Company Product Type Footprint
  3.5.3 Mumps Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Mumps Drug Market Size by Region
  4.1.1 Global Mumps Drug Sales Quantity by Region (2019-2030)
  4.1.2 Global Mumps Drug Consumption Value by Region (2019-2030)
  4.1.3 Global Mumps Drug Average Price by Region (2019-2030)
4.2 North America Mumps Drug Consumption Value (2019-2030)
4.3 Europe Mumps Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Mumps Drug Consumption Value (2019-2030)
4.5 South America Mumps Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Mumps Drug Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Mumps Drug Sales Quantity by Type (2019-2030)
5.2 Global Mumps Drug Consumption Value by Type (2019-2030)
5.3 Global Mumps Drug Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Mumps Drug Sales Quantity by Application (2019-2030)
6.2 Global Mumps Drug Consumption Value by Application (2019-2030)
6.3 Global Mumps Drug Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Mumps Drug Sales Quantity by Type (2019-2030)
7.2 North America Mumps Drug Sales Quantity by Application (2019-2030)
7.3 North America Mumps Drug Market Size by Country
  7.3.1 North America Mumps Drug Sales Quantity by Country (2019-2030)
  7.3.2 North America Mumps Drug Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Mumps Drug Sales Quantity by Type (2019-2030)
8.2 Europe Mumps Drug Sales Quantity by Application (2019-2030)
8.3 Europe Mumps Drug Market Size by Country
  8.3.1 Europe Mumps Drug Sales Quantity by Country (2019-2030)
  8.3.2 Europe Mumps Drug Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Mumps Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Mumps Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Mumps Drug Market Size by Region
  9.3.1 Asia-Pacific Mumps Drug Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Mumps Drug Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Mumps Drug Sales Quantity by Type (2019-2030)
10.2 South America Mumps Drug Sales Quantity by Application (2019-2030)
10.3 South America Mumps Drug Market Size by Country
  10.3.1 South America Mumps Drug Sales Quantity by Country (2019-2030)
  10.3.2 South America Mumps Drug Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Mumps Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Mumps Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Mumps Drug Market Size by Country
  11.3.1 Middle East & Africa Mumps Drug Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Mumps Drug Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Mumps Drug Market Drivers
12.2 Mumps Drug Market Restraints
12.3 Mumps Drug Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Mumps Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mumps Drug
13.3 Mumps Drug Production Process
13.4 Mumps Drug Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Mumps Drug Typical Distributors
14.3 Mumps Drug Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Mumps Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Mumps Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Beijing Minhai Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Beijing Minhai Biotechnology Co., Ltd Major Business
Table 5. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product and Services
Table 6. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
Table 8. Beijing Tiantan Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Beijing Tiantan Biological Products Co., Ltd. Major Business
Table 10. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product and Services
Table 11. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Beijing Tiantan Biological Products Co., Ltd. Recent Developments/Updates
Table 13. China National Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 14. China National Pharmaceutical Group Corporation Major Business
Table 15. China National Pharmaceutical Group Corporation Mumps Drug Product and Services
Table 16. China National Pharmaceutical Group Corporation Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. China National Pharmaceutical Group Corporation Recent Developments/Updates
Table 18. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 19. GlaxoSmithKline Plc Major Business
Table 20. GlaxoSmithKline Plc Mumps Drug Product and Services
Table 21. GlaxoSmithKline Plc Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GlaxoSmithKline Plc Recent Developments/Updates
Table 23. Organic Vaccines Basic Information, Manufacturing Base and Competitors
Table 24. Organic Vaccines Major Business
Table 25. Organic Vaccines Mumps Drug Product and Services
Table 26. Organic Vaccines Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Organic Vaccines Recent Developments/Updates
Table 28. Prometheon Pharma, LLC Basic Information, Manufacturing Base and Competitors
Table 29. Prometheon Pharma, LLC Major Business
Table 30. Prometheon Pharma, LLC Mumps Drug Product and Services
Table 31. Prometheon Pharma, LLC Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Prometheon Pharma, LLC Recent Developments/Updates
Table 33. Sinovac Biotech Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Sinovac Biotech Ltd. Major Business
Table 35. Sinovac Biotech Ltd. Mumps Drug Product and Services
Table 36. Sinovac Biotech Ltd. Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sinovac Biotech Ltd. Recent Developments/Updates
Table 38. Zydus Cadila Healthcare Limited Basic Information, Manufacturing Base and Competitors
Table 39. Zydus Cadila Healthcare Limited Major Business
Table 40. Zydus Cadila Healthcare Limited Mumps Drug Product and Services
Table 41. Zydus Cadila Healthcare Limited Mumps Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Zydus Cadila Healthcare Limited Recent Developments/Updates
Table 43. Global Mumps Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 44. Global Mumps Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Mumps Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 46. Market Position of Manufacturers in Mumps Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Mumps Drug Production Site of Key Manufacturer
Table 48. Mumps Drug Market: Company Product Type Footprint
Table 49. Mumps Drug Market: Company Product Application Footprint
Table 50. Mumps Drug New Market Entrants and Barriers to Market Entry
Table 51. Mumps Drug Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Mumps Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 53. Global Mumps Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 54. Global Mumps Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Mumps Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Mumps Drug Average Price by Region (2019-2024) & (USD/Pcs)
Table 57. Global Mumps Drug Average Price by Region (2025-2030) & (USD/Pcs)
Table 58. Global Mumps Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 59. Global Mumps Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 60. Global Mumps Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Mumps Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Mumps Drug Average Price by Type (2019-2024) & (USD/Pcs)
Table 63. Global Mumps Drug Average Price by Type (2025-2030) & (USD/Pcs)
Table 64. Global Mumps Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 65. Global Mumps Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 66. Global Mumps Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Mumps Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Mumps Drug Average Price by Application (2019-2024) & (USD/Pcs)
Table 69. Global Mumps Drug Average Price by Application (2025-2030) & (USD/Pcs)
Table 70. North America Mumps Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 71. North America Mumps Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 72. North America Mumps Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 73. North America Mumps Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 74. North America Mumps Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 75. North America Mumps Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 76. North America Mumps Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Mumps Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Mumps Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 79. Europe Mumps Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 80. Europe Mumps Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 81. Europe Mumps Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 82. Europe Mumps Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 83. Europe Mumps Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 84. Europe Mumps Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Mumps Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Mumps Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 87. Asia-Pacific Mumps Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 88. Asia-Pacific Mumps Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 89. Asia-Pacific Mumps Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 90. Asia-Pacific Mumps Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 91. Asia-Pacific Mumps Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 92. Asia-Pacific Mumps Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Mumps Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Mumps Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 95. South America Mumps Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 96. South America Mumps Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 97. South America Mumps Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 98. South America Mumps Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 99. South America Mumps Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 100. South America Mumps Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Mumps Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Mumps Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 103. Middle East & Africa Mumps Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 104. Middle East & Africa Mumps Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 105. Middle East & Africa Mumps Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 106. Middle East & Africa Mumps Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 107. Middle East & Africa Mumps Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 108. Middle East & Africa Mumps Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Mumps Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Mumps Drug Raw Material
Table 111. Key Manufacturers of Mumps Drug Raw Materials
Table 112. Mumps Drug Typical Distributors
Table 113. Mumps Drug Typical Customers

LIST OF FIGURES

Figure 1. Mumps Drug Picture
Figure 2. Global Mumps Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Mumps Drug Consumption Value Market Share by Type in 2023
Figure 4. RIT 4385 Examples
Figure 5. Schwarz Examples
Figure 6. Wistar RA 27/3 Examples
Figure 7. Others Examples
Figure 8. Global Mumps Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Mumps Drug Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Mumps Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Mumps Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Mumps Drug Sales Quantity (2019-2030) & (K Pcs)
Figure 16. Global Mumps Drug Average Price (2019-2030) & (USD/Pcs)
Figure 17. Global Mumps Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Mumps Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Mumps Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Mumps Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Mumps Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Mumps Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Mumps Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Mumps Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Mumps Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Mumps Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Mumps Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Mumps Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Mumps Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Mumps Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Mumps Drug Average Price by Type (2019-2030) & (USD/Pcs)
Figure 32. Global Mumps Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Mumps Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Mumps Drug Average Price by Application (2019-2030) & (USD/Pcs)
Figure 35. North America Mumps Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Mumps Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Mumps Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Mumps Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Mumps Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Mumps Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Mumps Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Mumps Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Mumps Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Mumps Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Mumps Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Mumps Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Mumps Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Mumps Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Mumps Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Mumps Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Mumps Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Mumps Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Mumps Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Mumps Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Mumps Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Mumps Drug Market Drivers
Figure 76. Mumps Drug Market Restraints
Figure 77. Mumps Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Mumps Drug in 2023
Figure 80. Manufacturing Process Analysis of Mumps Drug
Figure 81. Mumps Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications